Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans

Glucocorticoids (GC) are used for the treatment of inflammatory diseases, including various forms of arthritis. However, their use is limited, amongst others, by adverse effects on bone. The Wnt and bone formation inhibitor sclerostin was recently implicated in the pathogenesis of GC-induced osteopo...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiele, Sylvia, Hannemann, Anke, Winzer, Maria, Baschant, Ulrike, Weidner, Heike, Nauck, Matthias, Thakker, Rajesh V, Bornhäuser, Martin, Hofbauer, Lorenz C, Rauner, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612066/
https://www.ncbi.nlm.nih.gov/pubmed/31234141
http://dx.doi.org/10.1530/EC-19-0104

Ejemplares similares

Ejemplares similares